Company profile: Redwood Bioscience
1.1 - Company Overview
Company description
- Provider of precision protein-chemical engineering to develop optimized, novel biotherapeutics using site-specific modification technology to create homogenous biologic-synthetic conjugates; offering microscale perfusion-based cultivation for Pichia pastoris, E. coli recombinant proteins, CagA diagnostic proteins, and KRAS G12D recombinant protein vaccines.
Products and services
- Recombinant KRAS G12D Protein Vaccines: Mutation-specific vaccines targeting KRAS G12D, designed to elicit anti-tumor responses in cancer models for targeted vaccine development
- Microscale Perfusion-based Cultivation for Pichia pastoris Clone: Method to screen and optimize recombinant protein manufacturing in Pichia pastoris, using perfusion-based, high cell density fed-batch biomanufacturing for robust clone selection
- E. coli Recombinant Proteins: Bacterial-expression proteins produced using E. coli as host for various research and biotherapeutic applications, utilized as recombinant protein components across experimental and therapeutic contexts
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Redwood Bioscience
DJS Antibodies
HQ: United Kingdom
Website
- Description: Provider of antibody therapeutics and discovery technology targeting GPCRs to treat chronic inflammatory and fibrotic diseases. Offers HEPTAD, a proprietary platform to discover functional, first-in-class antibodies for complex protein targets; DJS 001, a first-in-class program for myeloid cell driven inflammatory disease; and DJS 002, a monoclonal antibody for fibrotic diseases without off-target side effects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DJS Antibodies company profile →
Navamedic
HQ: Sweden
Website
- Description: Provider of pharmaceutical and medtech products, marketing to patients, hospitals and pharmacies. Offers prescription and OTC medicines and healthcare products; the Sippi next-generation digital urine meter; and a portfolio including Eroxon gel to help men achieve an erection, Flexilev for Parkinson’s, Absolut Torr antiperspirant, MedMade micronutrient supplements, and PKU and obesity education/support programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Navamedic company profile →
Algernon Pharmaceuticals
HQ: Canada
Website
- Description: Provider of pharmaceutical R&D, in-licensing, and commercialization, advancing NP-120 (Ifenprodil) investigated for chronic cough and idiopathic pulmonary fibrosis, NP-251 (Repirinast) repurposed for chronic kidney disease, and AP-188 (DMT), a naturally occurring psychedelic compound explored for stroke and traumatic brain injury.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Algernon Pharmaceuticals company profile →
Kymab
HQ: United Kingdom
Website
- Description: Provider of fully human monoclonal antibody therapeutics focused on immune-mediated diseases and immuno-oncology, developed using proprietary, integrated IntelliSelect platforms. IntelliSelect Transgenic platforms contain a full diversity of human antibodies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kymab company profile →
Cellerix
HQ: Spain
Website
- Description: Provider of adult stem cell-based medicines and therapies for gastroenterology, dermatology, and immune-based diseases, including Cx401 for the treatment of complex perianal fistulas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellerix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Redwood Bioscience
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Redwood Bioscience
2.2 - Growth funds investing in similar companies to Redwood Bioscience
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Redwood Bioscience
4.2 - Public trading comparable groups for Redwood Bioscience
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →